Certificate of Dissolution of NeuBase Therapeutics, Inc. Filed with Delaware Secretary of State

Summary

NeuBase Therapeutics, Inc. has filed a Certificate of Dissolution with the State of Delaware, officially ending its corporate existence. The dissolution was approved by the board of directors and a majority of shareholders on June 26, 2024, in accordance with Delaware law. The document lists the company's directors and officers and provides a brief history of its name changes since incorporation in 2014. This filing is a formal legal step to dissolve the corporation under Delaware General Corporation Law.

Read More Arrow
EX-4.1 2 tm2417504d2_ex4-1.htm EXHIBIT 4.1

 

Exhibit 4.1

 

State of Delaware

 

Certificate of Dissolution

 

(Section 275)

 

NeuBase Therapeutics, Inc., a corporation organized and existing under the General Corporation Law of the State of Delaware (the “Corporation”), hereby certifies as follows:

 

 1.The dissolution of the Corporation (the “Dissolution”) has been duly authorized by the board of directors of the Corporation and the holders of a majority of the outstanding stock of the Corporation entitled to vote on a dissolution, in accordance with subsections (a) and (b) of Section 275 of the General Corporation Law of the State of Delaware.
   
 2.The date the Dissolution was authorized is June 26, 2024.
   
 3.The date of filing of the Corporation’s original Certificate of Incorporation with the Secretary of State of the State of Delaware was May 8, 2014 under the name Ohr Holdco, Inc. The Corporation changed its name to Ohr Pharmaceutical, Inc. on May 30, 2014. The Corporation subsequently changed its name to NeuBase Therapeutics, Inc. on July 12, 2019.
   
 4.The names and addresses of the directors and officers of the corporation are as follows:

 

Name Title Address
Dov A. Goldstein, M.D. Director 350 Technology Drive
Pittsburgh, PA 15219
Todd P. Branning Interim Chief Executive Officer and Chief Financial Officer 350 Technology Drive
Pittsburgh, PA 15219

 

  NeuBase Therapeutics, Inc.
   
  By: /s/ Todd Branning
  Name: Todd Branning
  Title: Interim Chief Executive Officer and Chief Financial Officer